China National Accord Medicines Corporation Ltd. (SHE: 000028)

Market Cap	14.69B
Revenue (ttm)	75.36B
Net Income (ttm)	1.48B
Shares Out	556.57M
EPS (ttm)	2.64
PE Ratio	10.73
Forward PE	15.91
Dividend	0.68 (2.32%)
Ex-Dividend Date	n/a

Volume	7,565,889
Open	30.26
Previous Close	30.45
Day's Range	29.12 - 30.39
52-Week Range	23.84 - 42.13
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 8, 2025

About China National Accord Medicines Corporation

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. It offers drugs, medical equipment, cargo transportation, warehousing, loading and unloading, glass instruments, cosmetics, sales of daily necessities, other business services, and other professional consulting services; agent services; and house leasing services. The company is also involved in the import and export of proprietary Chinese medicines, chemical preparations, antibiotics, biochemical drug...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1993
• Employees: 39,449
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000028

Financial Performance

In 2023, China National Accord Medicines Corporation's revenue was 75.48 billion, an increase of 2.77% compared to the previous year's 73.44 billion. Earnings were 1.60 billion, an increase of 7.57%.